MedPath
TGA Approval

SOGROYA somapacitan 5 mg (3.3 mg/mL) solution for injection prefilled pen (396877)

396877

SOGROYA somapacitan 5 mg (3.3 mg/mL) solution for injection prefilled pen

Novo Nordisk Pharmaceuticals Pty Ltd

September 18, 2023

Medicine

Medicine

Active

Registered

Active Ingredients

somapacitan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.